Medicamen Biotech Limited — Others, 12-08-2025: Change in Management

Medicamen Biotech's Board has approved significant leadership updates. Two new Independent Directors, Mr. Sham Goel and Mr. Shaival Saurabh, have been appointed for five-year terms, following the Nomination and Remuneration Committee's review. These appointments address upcoming vacancies as current independent directors' terms expire, ensuring continuity. Additionally, Mr. Ashwani Kumar Sharma's designation has changed from Non-Executive to Whole Time Director (Executive Director) for a five-year term. All these key appointments and changes are subject to shareholder approval, aiming to strengthen the company's governance and strategic direction.